Multi-partner grant awarded for the validation of Genedrive® CYP2C19 ID Kit in time-critical NHS settings
ValiRx PLC – Expanded agreement with University of Barcelona
ValiRx Plc (AIM: VAL), a life science company focusing on early-stage cancer therapeutics and women’s health, is today pleased to announce that the evaluation agreement announced on 14 February 2022
The former chief scientist of China concedes that the theory of a laboratory leak causing Covid cannot be entirely dismissed.
The former leader of China’s Centre for Disease Control implies that an official investigation was carried out by Beijing into the Wuhan lab.
Genedrive PLC – NICE recommends CYP2C19 genotyping
Genedrive plc (AIM: GDR), a leading provider of point-of-care molecular diagnostics, has announced that the UK’s National Institute for Health and Care Excellence (NICE) is advising in a draft guideline
Genedrive PLC (AIM:GDR) Commence of roll out in Greater Manchester
Genedrive ® MT-RNR1 to commence roll out in Greater Manchester Project to follow NICE final recomendations scheduled for end of this month
Versarien PLC (AIM:VRS) Further re Resignation of Chief Executive Officer
Versarien plc (AIM: VRS), the advanced materials engineering group, announces that further to the announcement made on 10 March 2023, the Company confirms that Neill Ricketts’ resignation as Chief Executive
According to the US Department of Energy, it is probable that Covid-19 originated from a laboratory leak.
According to the Wall Street Journal, a recently updated and classified 2021 US Department of Energy study, provided to senior American lawmakers and the White House, suggests that the virus
Genedrive PLC (AIM:GDR) AIHL test preliminary recommendation by NICE
Antibiotic Induced Hearing Loss test receives preliminary recommendation by NICE NICE enters public consultation phase of Early Value Assessment of the Genedrive® MT-RNR1 System
ValiRx PLC (AIM:VAL) Operational Update
London, UK – ValiRx Plc (AIM: VAL), a life science company focusing on early-stage cancer therapeutics and women’s health, is pleased to announce today the signature of a lease for
ValiRx PLC (AIM:VAL) Launch of Broker Offer to raise a maximum of £500,000
Launch of Broker Offer to raise a maximum of £500,000
Big Oil Bets Billions on Global Climate Catastrophe
According to Carbon Tracker (a non-profit think tank), the world’s largest oil producers are spending billions on fossil fuel projects. These will be required if the world fails to meet